Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Cost of sales as % of net product revenues by Year
Cost of sales as % of net product revenues (%) (%)
Vertex Pharmaceuticals Cost of sales as % of net product revenues: 13.8% in FY2025, down 0.1 pts from a year earlier.
Where the FY2025 figure comes from
“Our cost of sales as a percentage of our net product revenues decreased from 13.9% in 2024 to 13.8% in 2025 as a result of a lower overall royalty rate for our CF medicines, partially offset by changes in our product mix, and investments in network expansion and manufacturing process improvements.”
Source: Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K MD&A (Cost of Sales Table).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cost of sales as % of net product revenues (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.8% | -0.1 pts | Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 13.9% | +0.9 pts | Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 13.0% | +1.0 pts | Form 10-K (vrtx-20241231.htm, filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 12.0% | 0.0 pts | Form 10-K (vrtx-20231231.htm, filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 12.0% | 0.0 pts | Form 10-K (vrtx-20221231.htm, filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 12.0% | -1.0 pts | Form 10-K (vrtx-20211231.htm, filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 13.0% | 0.0 pts | Form 10-K (vrtx-20201231.htm, filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 13.0% | – | Form 10-K (vrtx-20201231.htm, filed 2021-02-11) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Cost of sales as % of net product revenues (%), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/cogs-pct-prod-rev
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.